Literature DB >> 12960751

Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population.

Tae-Youn Jun1, Chi-Un Pae, Jeong-Ho Chae, Won-Myong Bahk, Kwang-Soo Kim, Alessandro Serretti.   

Abstract

OBJECTIVE: The present study was aimed at examining the association between the -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder (MDD) in the Korean population.
METHODS: One hundred and eight in-patients with MDD and 125 healthy controls participated in this study. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: Genotype and allele distributions in patients with MDD (P=0.024 and P=0.0125, respectively), were significantly different from those of the controls. In particular, subjects with MDD had an increased frequency of the TNF2 (A) allele.
CONCLUSION: The present study suggests that the -G308A tumour necrosis factor-alpha gene polymorphism may have a potential role for susceptibility to MDD in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960751     DOI: 10.1097/00041444-200309000-00008

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  36 in total

Review 1.  The heritability of postpartum depression.

Authors:  Elizabeth J Corwin; Ruth Kohen; Monica Jarrett; Brian Stafford
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

2.  Early maternal separation leads to down-regulation of cytokine gene expression.

Authors:  J J Dimatelis; N S Pillay; A K Mutyaba; V A Russell; W M U Daniels; D J Stein
Journal:  Metab Brain Dis       Date:  2012-04-13       Impact factor: 3.584

3.  Association study between functional polymorphisms in the TNF-alpha gene and obsessive-compulsive disorder.

Authors:  Carolina Cappi; Renan Kawano Muniz; Aline Santos Sampaio; Quirino Cordeiro; Helena Brentani; Selma A Palácios; Andrea H Marques; Homero Vallada; Eurípedes Constantino Miguel; Luiza Guilherme; Ana Gabriela Hounie
Journal:  Arq Neuropsiquiatr       Date:  2012-02       Impact factor: 1.420

Review 4.  Molecular epidemiology, cancer-related symptoms, and cytokines pathway.

Authors:  Cielito C Reyes-Gibby; Xifeng Wu; Margaret Spitz; Razelle Kurzrock; Michael Fisch; Eduardo Bruera; Sanjay Shete
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

Review 5.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 6.  Postpartum depression: A systematic review of the genetics involved.

Authors:  Tiago Castro E Couto; Mayra Yara Martins Brancaglion; António Alvim-Soares; Lafaiete Moreira; Frederico Duarte Garcia; Rodrigo Nicolato; Regina Amélia Lopes P Aguiar; Henrique Vitor Leite; Humberto Corrêa
Journal:  World J Psychiatry       Date:  2015-03-22

Review 7.  Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later.

Authors:  Gregory F Oxenkrug
Journal:  Isr J Psychiatry Relat Sci       Date:  2010       Impact factor: 0.481

Review 8.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

Review 9.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

Authors:  Rushaniya A Khairova; Rodrigo Machado-Vieira; Jing Du; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-19       Impact factor: 5.176

10.  Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.

Authors:  Tanel Traks; Kati Koido; Triin Eller; Eduard Maron; Külli Kingo; Veiko Vasar; Eero Vasar; Sulev Kõks
Journal:  BMC Med Genet       Date:  2008-12-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.